|
TRIM5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.95779999995405E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.68280000001353E-06 |
| Normal-vs-Stage2 |
8.763900E-03 |
| Normal-vs-Stage3 |
4.944100E-03 |
| Normal-vs-Stage4 |
7.981600E-03 |
| Stage1-vs-Stage2 |
4.079600E-01 |
| Stage1-vs-Stage3 |
1.114360E-01 |
| Stage1-vs-Stage4 |
7.681700E-02 |
| Stage2-vs-Stage3 |
7.019400E-01 |
| Stage2-vs-Stage4 |
5.930800E-01 |
| Stage3-vs-Stage4 |
8.748000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.18159999998413E-06 |
| Normal-vs-AfricanAmerican |
1.033380E-01 |
| Normal-vs-Asian |
2.462600E-01 |
| Caucasian-vs-AfricanAmerican |
6.820300E-02 |
| Caucasian-vs-Asian |
6.476200E-01 |
| AfricanAmerican-vs-Asian |
7.907000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.22689999999082E-05 |
| Normal-vs-Female |
3.68299999999877E-05 |
| Male-vs-Female |
8.424800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.125000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.50690000000542E-05 |
| Normal-vs-Age(61-80Yrs) |
6.2895999999979E-05 |
| Normal-vs-Age(81-100Yrs) |
1.216800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.932600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.053200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.869000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.113400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.313000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.376000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.10680000004115E-06 |
| Normal-vs-Grade 2 |
2.29480000002447E-06 |
| Normal-vs-Grade 3 |
9.74969999999464E-05 |
| Normal-vs-Grade 4 |
6.764400E-02 |
| Grade 1-vs-Grade 2 |
4.071700E-02 |
| Grade 1-vs-Grade 3 |
1.286260E-02 |
| Grade 1-vs-Grade 4 |
5.219600E-03 |
| Grade 2-vs-Grade 3 |
4.830200E-01 |
| Grade 2-vs-Grade 4 |
4.574300E-02 |
| Grade 3-vs-Grade 4 |
1.101590E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.88149995583586E-09 |
| Normal-vs-ccB subtype |
1.699680E-02 |
| ccA subtype-vs-ccB subtype |
9.87369999999599E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.7675999999951E-05 |
| Normal-vs-N1 |
4.055800E-01 |
| N0-vs-N1 |
4.603000E-01 |
|
|
